Care Cues: Shared Decision-Making in Prostate Cancer

Kelvin Moses, MD; Meredith Donahue, APRN-BC


July 05, 2022

Prostate cancer will affect about 1 in 8 men. Options for surgery, radiation, and pharmacologic therapy intended to prevent disease progression can have dramatic effects on urinary and bowel function, body image, and sexuality. The optimal management strategy must balance risk and benefit, and it varies from patient to patient.

In this episode of Care Cues, Dr Kelvin Moses and nurse practitioner Meredith Donahue, from Vanderbilt University Medical Center in Nashville, Tennessee, discuss the challenges they face when communicating treatment options with their prostate cancer patients.

The colleagues examine how a shared decision-making process that directly involves the patient and his family can lead to more positive outcomes.

They also discuss how cultural considerations often play a role in the way that patients prefer to manage their disease, and how side-effect tolerance varies between patients and can also affect treatment options and decisions.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.